InsidersTradesSigma
Discover the full record of transactions filed by Cole Hugh M, Directeur Commercial. Officer active across 1 companies, notably Jounce Therapeutics, Inc.. Aggregated, 4 filings have been logged. Total volume traded: €45k. The latest transaction was disclosed on 1 February 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Hugh M. Cole is the Chief Business Officer of Jounce Therapeutics, Inc. He is responsible for business strategy and partnership development. With significant experience in the biopharmaceutical industry, he plays a key role in expanding Jounce's operations and achieving its growth objectives.